Literature DB >> 11304952

[Sero-epidemiologic profile of toxoplasmosis in northern Tunisia].

A Bouratbine1, E Siala, M K Chahed, K Aoun, R Ben Ismail.   

Abstract

Toxoplasma antibodies prevalence was studied in the north of Tunisia where a mild climate prevails. Two groups of individuals were investigated: 857 living in rural area and 564 living in urb town. Sera were analysed by ELISA and indirect immunofluorescence. The overall prevalence was 58.4%. It roses from 24.5% at ten years to 52.1% at 20 years of age. A maximum level, around 70%, was reached by about 30 years. The risk of acute infection after this age seemed low as judging by the proportion of high antibodies titers observed in this group (14.2% before 30 years vs 3.7% after). A significantly higher prevalence was detected in urban residents (67% vs 52.8%). In this group, the rate of seroconversion seems the highest between ten and 20 years of age and the majority of women are infected before reaching childbearing age. In the rural area, the seropositivity is lower between ten-20 years and many women at childbearing age still susceptible to toxoplasmosis. The risk of acute infection seems higher in the youngest ones as showed by the proportion of high antibodies titers observed in the 18-30 age group (9.2%) compared to the one observed after 30 years (1.9%).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304952     DOI: 10.1051/parasite/2001081061

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  16 in total

1.  Direct genotypic characterization of Toxoplasma gondii strains associated with congenital toxoplasmosis in Tunisia (North Africa).

Authors:  Sonia Boughattas; Rym Ben-Abdallah; Emna Siala; Olfa Souissi; Karim Aoun; Aïda Bouratbine
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

2.  Seroprevalence of Toxoplasma IgG Antibodies in HIV Positive Patients in and Around Khammam, Telangana State.

Authors:  Basavaraju Anuradha; Chilupuri Preethi
Journal:  J Clin Diagn Res       Date:  2014-09-20

3.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

4.  Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.

Authors:  Yosr Boudaouara; Karim Aoun; Rania Maatoug; Olfa Souissi; Aïda Bouratbine; Rym Ben Abdallah
Journal:  Am J Trop Med Hyg       Date:  2018-04-12       Impact factor: 2.345

5.  Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva.

Authors:  Nouha Chahed Bel-Ochi; Aïda Bouratbine; Mohamed Mousli
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

6.  [Serological analysis of toxoplasmosis during pregnancy: risk assessment and perspectives of prenatal screening at the University Hospital of Bobo Dioulasso in Burkina Faso].

Authors:  Sanata Bamba; Der Adolphe Some; Cathy Chemla; Régine Geers; Tinga Robert Guiguemde; Isabelle Villena
Journal:  Pan Afr Med J       Date:  2012-06-22

7.  Toxoplasma gondii infections among pregnant women, children and HIV-seropositive persons in Accra, Ghana.

Authors:  Irene Ayi; Augustine Odoi-Kpoti Sowah; Emmanuel Awusah Blay; Takashi Suzuki; Nobuo Ohta; Patrick F Ayeh-Kumi
Journal:  Trop Med Health       Date:  2016-06-01

8.  Prevalence and genotyping ofToxoplasma gondii among Saudi pregnant women in Saudi Arabia.

Authors:  Jawahir Alghamdi; Maha Hussein Elamin; Samia Alhabib
Journal:  Saudi Pharm J       Date:  2015-05-23       Impact factor: 4.330

9.  Molecular prevalence of Toxoplasma gondii DNA in goats' milk and seroprevalence in Northwest Tunisia.

Authors:  Safa Amairia; Mariem Rouatbi; Mohamed R Rjeibi; Hanen Nouasri; Limam Sassi; Moez Mhadhbi; Mohamed Gharbi
Journal:  Vet Med Sci       Date:  2016-03-07

10.  Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation.

Authors:  F Nogareda; Y Le Strat; I Villena; H De Valk; V Goulet
Journal:  Epidemiol Infect       Date:  2013-11-14       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.